Yongqun He Selected Research

Deslanoside (Cedilanid-D)

10/2017

Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongqun He Research Topics

Disease

18	Infections 01/2022 - 12/2002
10	COVID-19 01/2022 - 01/2020
8	Neoplasms (Cancer) 01/2021 - 01/2011
7	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2008
7	Brucellosis (Malta Fever) 01/2018 - 05/2002
5	Drug-Related Side Effects and Adverse Reactions 12/2019 - 01/2011
4	Noncommunicable Diseases 01/2021 - 01/2011
3	Hypersensitivity (Allergy) 01/2016 - 01/2011
2	Human Influenza (Influenza) 01/2021 - 01/2017
2	Intestinal Diseases (Diseases, Intestinal) 01/2021 - 01/2019
2	Autolysis 01/2021 - 01/2019
2	Latent Tuberculosis 01/2020 - 11/2017
2	Sepsis (Septicemia) 01/2018 - 09/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 01/2014
2	Tuberculosis (Tuberculoses) 01/2016 - 03/2010
2	Bovine Brucellosis (Bang's Disease) 01/2011 - 12/2002
1	Thrombosis (Thrombus) 01/2022
1	Myocarditis (Carditis) 01/2022
1	Dysbiosis 01/2021
1	Rheumatoid Arthritis 01/2021
1	Kidney Diseases (Kidney Disease) 11/2020
1	Pneumococcal Infections 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Rheumatic Diseases (Rheumatism) 12/2017
1	Yellow Fever 12/2017
1	Diarrhea 10/2017
1	Anorexia 10/2017
1	African Swine Fever 03/2017
1	Vaccinia 03/2017
1	Poliomyelitis (Polio) 01/2017
1	Measles 01/2017
1	Smallpox (Variola) 01/2017
1	Hepatitis A (Hepatitis, Infectious) 10/2016
1	Pathologic Processes 01/2016
1	Dysuria 01/2016
1	Lymphadenitis (Adenitis) 01/2016
1	Cardiotoxicity 01/2016
1	Hematuria 01/2016
1	Cyanosis 01/2016
1	Cough 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Chills 01/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016
1	Animal Diseases 01/2016
1	Lymphadenopathy 01/2016

Drug/Important Bio-Agent (IBA)

35	VaccinesIBA 01/2022 - 05/2002
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2002
6	AntigensIBA 01/2022 - 05/2002
6	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
3	Biological ProductsIBA 11/2020 - 01/2016
2	COVID-19 VaccinesIBA 01/2022 - 12/2021
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021 - 01/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
2	EpitopesIBA 01/2021 - 03/2010
2	CytokinesIBA 01/2021 - 09/2015
2	trimethylaminocarboxyldihydroboran (TCDB)IBA 01/2021 - 01/2019
2	Subunit VaccinesIBA 11/2017 - 03/2010
2	Caspase 2IBA 09/2015 - 08/2009
2	DNA VaccinesIBA 01/2014 - 01/2014
1	Brucella VaccineIBA 01/2022
1	HydrolasesIBA 01/2021
1	Interleukin-13IBA 01/2021
1	AntibodiesIBA 01/2021
1	AutoantigensIBA 01/2021
1	Protein SIBA 01/2021
1	InterferonsIBA 01/2021
1	InterleukinsIBA 01/2021
1	small cardioactive peptide BIBA 01/2018
1	Polysaccharides (Glycans)IBA 01/2018
1	benzimidazoleIBA 01/2018
1	Conjugate VaccinesIBA 01/2018
1	Immune Sera (Antisera)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 12/2017
1	Pentacyclic TriterpenesIBA 12/2017
1	TriterpenesIBA 12/2017
1	DiterpenesIBA 12/2017
1	Cardiovascular AgentsIBA 10/2017
1	Indapamide FDA LinkGeneric 10/2017
1	Reserpine (Serpasil)FDA Link 10/2017
1	Deslanoside (Cedilanid-D)FDA Link 10/2017
1	Digoxin (Digitek)FDA LinkGeneric 10/2017
1	FluBlokIBA 01/2017
1	Combined VaccinesIBA 10/2016
1	twinrixIBA 10/2016
1	Engerix-BIBA 10/2016
1	Hepatitis A Vaccines (Hepatitis A Vaccine)IBA 10/2016
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 10/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	Imatinib Mesylate (Gleevec)FDA Link 01/2016
1	Trastuzumab (Herceptin)FDA Link 01/2016
1	Dasatinib (BMS 354825)FDA Link 01/2016
1	Tuberculosis VaccinesIBA 01/2016
1	Mitogen-Activated Protein KinasesIBA 01/2016
1	Attenuated VaccinesIBA 01/2016
1	C-Reactive ProteinIBA 01/2016
1	Lapatinib (GW572016)FDA Link 01/2016
1	Cancer VaccinesIBA 01/2016
1	Synthetic Vaccines (Recombinant Vaccines)IBA 11/2015

Therapy/Procedure

2	Precision Medicine 01/2022 - 11/2020
2	Therapeutics 01/2021 - 01/2019